Home
Contact Palatin
Site Map
.
.
.
.
.
.
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Corporate Fact Sheet
Bremelanotide Fact Sheet
MIDAS™ Fact Sheet
Melanocortin Fact Sheet
Press Releases
2002
2003
2004
2005
all
Displaying releases:
1-15
|
16-30
|
31-45
|
46-60
|
61-75
|
76-90
|
91-105
|
106-120
|
121-135
|
136-150
|
151-165
|
166-180
|
181-195
|
196-203
Nov-03-2005
Palatin Technologies to Report First Quarter, Fiscal Year 2006 Financial Results; Teleconference and Webcast on November 8th
Oct-31-2005
Palatin Technologies to Present at Two Investor Conferences in November 2005
Oct-14-2005
Palatin Technologies to Present at the 2005 BIO InvestorForum
Sep-27-2005
Palatin Technologies, Inc. Receives $10 Million Payment From King Pharmaceuticals, Inc.
Sep-26-2005
Palatin Technologies to Present at the UBS Global Life Sciences Conference
Sep-20-2005
J. Stanley Hull Joins Palatin Technologies, Inc. Board of Directors
Sep-14-2005
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2005 Results; Teleconference and Webcast Being held Today at 10:00 a.m. EDT
Sep-09-2005
Palatin Technologies, Inc. to Report Fourth Quarter, Fiscal Year 2005 Financial Results & Host Teleconference and Webcast on September 14, 2005
Aug-30-2005
Palatin Technologies to Present at the Thomas Weisel Partners 2005 Healthcare Conference
Aug-03-2005
King Pharmaceuticals and Palatin Technologies Initiate Phase IIb Clinical Trials Evaluating PT-141 in Patients Suffering from Erectile Dysfunction
Jun-23-2005
Palatin Technologies Settles Claim in License Agreement Dispute with Competitive Technologies
Jun-15-2005
Mallinckrodt and Palatin Technologies, Inc. Agree on Licensing Terms for European Marketing Rights for NeutroSpec(TM)
Jun-14-2005
Palatin Technologies to Present at the BIO 2005 Annual International Convention
Jun-14-2005
New Diagnostic Tool 'Lights Up' Infection for Clinical Certainty in Dangerous Appendicitis Cases
May-18-2005
Palatin Technologies to Present at The Fourth Annual Needham Biotechnology Conference
Overview
Press Releases
Event Calendar
Webcasts
SEC Filings
Analyst Coverage
Corporate Governance
Information Request
E-Mail Alerts
Investor Materials
Overview
Executive Management
Board of Directors
Overview
Employee Benefits
Career Opportunities
Overview
Press Releases
Presentations
Events Calendar
Webcasts
Media Kit
Overview
PL-3994 for CHF
PL-3994 for Asthma
PL-3994 for Hypertension
Bremelanotide
PL-6983
Obesity